Zoetis (ZTS) Other Working Capital Changes (2012 - 2026)
Zoetis (ZTS) reported Other Working Capital Changes of $66.0 million for Q1 2026, up 43.48% year-over-year from $46.0 million in Q1 2025, and up 760.0% quarter-over-quarter from -$10.0 million in Q4 2025.
Zoetis (ZTS) Other Working Capital Changes (2012 - 2026) Analysis & Trends
Zoetis (ZTS) has 15 years of Other Working Capital Changes data on file, last reported at $66.0 million in Q1 2026.
- Other Working Capital Changes for Q1 2026 came in at $66.0 million, up 43.48% year-over-year; the trailing twelve-month figure through Mar 2026 was $185.0 million (up 1333.33% YoY), and the FY2025 annual result was $165.0 million, up 417.31% from the prior year.
- Other Working Capital Changes improved to $66.0 million in Q1 2026 per ZTS's latest filing, from -$10.0 million in the prior quarter.
- Over five years, Other Working Capital Changes peaked at $116.0 million in Q2 2025 and troughed at -$66.0 million in Q4 2024.
- A 5-year average of $14.1 million and a median of $13.0 million in 2025 frame the typical range for Other Working Capital Changes.
- The sharpest annual moves came in 2022 and 2023: Other Working Capital Changes slumped 466.67% in 2022, then surged 2300.0% in 2023.
- A 5-year view of Other Working Capital Changes shows it stood at -$55.0 million in 2022, then jumped by 56.36% to -$24.0 million in 2023, then plunged by 175.0% to -$66.0 million in 2024, then soared by 84.85% to -$10.0 million in 2025, then soared by 760.0% to $66.0 million in 2026.
- Business Quant data shows ZTS's Other Working Capital Changes at $66.0 million in Q1 2026, -$10.0 million in Q4 2025, and $13.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn |
| 10 | Liquidia | 5.63 Bn | 5.40 Bn | 121.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 66.00 Mn |
| Mar 31, 2026 | 66.00 Mn |
| Dec 31, 2025 | -10.00 Mn |
| Dec 31, 2025 | -10.00 Mn |
| Sep 30, 2025 | 13.00 Mn |
| Sep 30, 2025 | 13.00 Mn |
| Jun 30, 2025 | 116.00 Mn |
| Jun 30, 2025 | 116.00 Mn |
| Mar 31, 2025 | 46.00 Mn |
| Mar 31, 2025 | 46.00 Mn |
| Dec 31, 2024 | -66.00 Mn |
| Dec 31, 2024 | -66.00 Mn |
| Sep 30, 2024 | -21.00 Mn |
| Sep 30, 2024 | -21.00 Mn |
| Jun 30, 2024 | 26.00 Mn |
| Jun 30, 2024 | 26.00 Mn |
| Mar 31, 2024 | 9.00 Mn |
| Mar 31, 2024 | 9.00 Mn |
| Dec 31, 2023 | -24.00 Mn |
| Dec 31, 2023 | -24.00 Mn |